Stay updated by reading our latest news

A multicenter study led by the Netherlands Cancer Institute used Kaiku Health digital patient management platform to investigate the use of digital patient monitoring and support of patients with advanced melanoma. The results published at ESMO 2022 annual conference suggest that Kaiku Health can be used to support patients and to collect real-world evidence. They...

Last year Kaiku Health, a leading digital therapeutics platform for cancer care, announced its collaboration with Novartis, a leading global medicines company, in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership. “Our goal is to make precision...

Research conducted at the University Hospital Geneva aimed to investigate the potential correlation between symptom burden reported through electronic patient-reported outcomes (ePRO) and the serological response to SARS-CoV-2 vaccines on cancer patients. The promising results are presented at ASCO 2022 this week. The results show that a machine learning model based on patient-reported symptom data...

Kaiku Health is taking part in a study assessing the use of an electronic Patient-Reported Outcome (ePRO)-based model of care to evaluate onset of symptomatic immune-related adverse events in cancer patients and their detection by healthcare providers. This phase-II randomised controlled trial, comparing the ePRO-based model of care to the current standard model of care,...

Kaiku Health, a leading digital therapeutics platform in cancer care, and Roche, a leading global healthcare company, are entering a strategic partnership in digital patient monitoring and management (DPMM). Kaiku Health and Roche aim to deploy digital tools to provide real-time symptom management by patients and Health Care Providers (HCPs), improve patient support, and provide...